As global drugmakers cut costs before patents expire, they are increasing their search for China's experimental medicines.

Biomica, a subsidiary of Evogene, and Lishan Biotech have agreed to a worldwide, exclusive licensing deal for a ...

HCW Biologics Inc. and WY Biotech Co., Ltd. have finalized a licensing agreement for the development and commercialization of HCW11-006, a novel immunotherapy targeting age-related diseases and cancer ...

This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taking the lead in business development, with ...

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals. Vir Biotechnology's chronic hepatitis delta ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / August 12, 2025 / Amphastar Pharmaceuticals, Inc. (AMPH) ("Amphastar"), a biopharmaceutical company focused on developing, manufacturing, and marketing complex ...